Zhirui Zhang, Changxing Liu, Xufang Tan, Jiadi Wang, Jing Yao
{"title":"视力丧失作为日益上升的全球健康挑战：高空腹血糖负担的综合分析和2035年的预测","authors":"Zhirui Zhang, Changxing Liu, Xufang Tan, Jiadi Wang, Jing Yao","doi":"10.1002/dmrr.70054","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Vision loss caused by high fasting plasma glucose (HFG) is a growing global health concern. This study evaluates the global and regional burden of HFG-attributable vision loss from 1990 to 2021 and projects future trends through 2035.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Using Global Burden of Disease (GBD) 2021 data, we assessed disability-adjusted life years (DALYs) across 204 countries, stratified by gender, age, and Sociodemographic Index (SDI). Temporal trends were analysed using Joinpoint regression, and projections were made using ARIMA modelling.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Global DALYs due to HFG-related vision loss rose from 613,694 in 1990 to 1,674,401 in 2021. South Asia and Sub-Saharan Africa experienced the highest burdens, especially among females and older adults. Although age-standardized DALY rates slightly declined globally, they remained elevated in low-SDI regions. Projections suggest a continued increase through 2035.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The burden of vision loss due to HFG is rising, with stark regional and demographic disparities. Urgent, targeted interventions are needed to reduce this growing health burden, particularly in low-SDI areas and among high-risk populations.</p>\n </section>\n </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"41 5","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70054","citationCount":"0","resultStr":"{\"title\":\"Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035\",\"authors\":\"Zhirui Zhang, Changxing Liu, Xufang Tan, Jiadi Wang, Jing Yao\",\"doi\":\"10.1002/dmrr.70054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Vision loss caused by high fasting plasma glucose (HFG) is a growing global health concern. This study evaluates the global and regional burden of HFG-attributable vision loss from 1990 to 2021 and projects future trends through 2035.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Using Global Burden of Disease (GBD) 2021 data, we assessed disability-adjusted life years (DALYs) across 204 countries, stratified by gender, age, and Sociodemographic Index (SDI). Temporal trends were analysed using Joinpoint regression, and projections were made using ARIMA modelling.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Global DALYs due to HFG-related vision loss rose from 613,694 in 1990 to 1,674,401 in 2021. South Asia and Sub-Saharan Africa experienced the highest burdens, especially among females and older adults. Although age-standardized DALY rates slightly declined globally, they remained elevated in low-SDI regions. Projections suggest a continued increase through 2035.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The burden of vision loss due to HFG is rising, with stark regional and demographic disparities. Urgent, targeted interventions are needed to reduce this growing health burden, particularly in low-SDI areas and among high-risk populations.</p>\\n </section>\\n </div>\",\"PeriodicalId\":11335,\"journal\":{\"name\":\"Diabetes/Metabolism Research and Reviews\",\"volume\":\"41 5\",\"pages\":\"\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70054\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes/Metabolism Research and Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/dmrr.70054\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes/Metabolism Research and Reviews","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dmrr.70054","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035
Background
Vision loss caused by high fasting plasma glucose (HFG) is a growing global health concern. This study evaluates the global and regional burden of HFG-attributable vision loss from 1990 to 2021 and projects future trends through 2035.
Methods
Using Global Burden of Disease (GBD) 2021 data, we assessed disability-adjusted life years (DALYs) across 204 countries, stratified by gender, age, and Sociodemographic Index (SDI). Temporal trends were analysed using Joinpoint regression, and projections were made using ARIMA modelling.
Results
Global DALYs due to HFG-related vision loss rose from 613,694 in 1990 to 1,674,401 in 2021. South Asia and Sub-Saharan Africa experienced the highest burdens, especially among females and older adults. Although age-standardized DALY rates slightly declined globally, they remained elevated in low-SDI regions. Projections suggest a continued increase through 2035.
Conclusions
The burden of vision loss due to HFG is rising, with stark regional and demographic disparities. Urgent, targeted interventions are needed to reduce this growing health burden, particularly in low-SDI areas and among high-risk populations.
期刊介绍：
Diabetes/Metabolism Research and Reviews is a premier endocrinology and metabolism journal esteemed by clinicians and researchers alike. Encompassing a wide spectrum of topics including diabetes, endocrinology, metabolism, and obesity, the journal eagerly accepts submissions ranging from clinical studies to basic and translational research, as well as reviews exploring historical progress, controversial issues, and prominent opinions in the field. Join us in advancing knowledge and understanding in the realm of diabetes and metabolism.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
